VECTIBIX conc perf 100 mg/5ml flac 5 ml
7680578720017
CH-57872
L01FE02
07.16.1.
Reimbursement limitations:
VECTIBIX4
Uniquement après accord préalable de prise en charge par l’assureur-maladie, après consultation préalable du médecin-conseil:
…
1 / 2
google
Details
- Product number
- 5787201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- panitumumabum 100 mg, natrii acetas trihydricus, natrii chloridum, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 17.25 mg.
Articles (1)
Vectibix 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
17.25 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 426.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2010
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57872
- Drug name
- Vectibix, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FE02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 14/10/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VECTIBIX conc perf 100 mg/5ml flac 5 ml
- Description (DE)
- VECTIBIX Inf Konz 100 mg/5ml Durchstf 5 ml
- Market launch
- 14/10/2008
- Narcotic (BTM)
- No